Literature DB >> 11070442

Is alexithymia a permanent feature in depressed patients? Results from a 6-month follow-up study.

K Honkalampi1, J Hintikka, P Saarinen, J Lehtonen, H Viinamäki.   

Abstract

BACKGROUND: A six-month follow-up study was conducted to determine whether alexithymia is a permanent feature in 169 depressed outpatients.
METHODS: Diagnosis of depression was confirmed by means of the Structured Clinical Interview for DSM-III-R (SCID-I). Alexithymia was screened using the 20-item version of the Toronto Alexithymia Scale (TAS-20) and severity of depression was assessed using the 21-item Beck Depression Inventory (BDI).
RESULTS: Almost 40% of the patients were considered alexithymic at baseline, but only 23% at follow-up. Alexithymic patients were more often moderately or severely depressed than other patients in both study phases. The BDI scores explained 23% (at baseline) and 42% (at follow-up) of the variation in TAS-20 scores. The decrease in the TAS-20 scores was associated with a concurrent decrease in BDI scores.
CONCLUSIONS: Alexithymic patients with depressive disorders do not appear to form a stable group. On the contrary, alexithymia seems to change as a function of depression. In the light of these results, alexithymia appears not to be a stable personality trait among depressed patients, and furthermore, it seems possible that alexithymic features respond to psychiatric treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11070442     DOI: 10.1159/000012412

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  21 in total

1.  Clinical-epidemiological characteristics of mental disturbances comorbid with somatic pathology in patients attending a regional polyclinic.

Authors:  V F Lebedeva; V Ya Semke
Journal:  Neurosci Behav Physiol       Date:  2008-06

Review 2.  Development of alexithymic personality features.

Authors:  Max Karukivi; Simo Saarijärvi
Journal:  World J Psychiatry       Date:  2014-12-22

3.  Alexithymia in female patients with eating disorders.

Authors:  O Montebarocci; M Codispoti; P Surcinelli; E Franzoni; B Baldaro; N Rossi
Journal:  Eat Weight Disord       Date:  2006-03       Impact factor: 4.652

4.  Alexithymia and Somatization in Depressed Patients: The Role of the Type of Somatic Symptom Attribution.

Authors:  Okan Taycan; Armağan Özdemir; Serap Erdoğan Taycan
Journal:  Noro Psikiyatr Ars       Date:  2017-01-19       Impact factor: 1.339

5.  Obesity, alexithymia and psychopathology: a case-control study.

Authors:  F Pinna; L Lai; S Pirarba; W Orrù; F Velluzzi; A Loviselli; B Carpiniello
Journal:  Eat Weight Disord       Date:  2011-02-16       Impact factor: 4.652

6.  Impact of Alexithymia on the Lipid Profile in Major Depressed Individuals.

Authors:  Camille Point; Benjamin Wacquier; Marjorie Dosogne; Mohammed Al Faker; Hadrien Willame; Gwenolé Loas; Matthieu Hein
Journal:  J Lipids       Date:  2022-06-16

7.  Interpersonal problem areas and alexithymia in adolescent girls with loss of control eating.

Authors:  Sarah Shafer Berger; Camden Elliott; Lisa M Ranzenhofer; Lauren B Shomaker; Louise Hannallah; Sara E Field; Jami F Young; Tracy Sbrocco; Denise E Wilfley; Jack A Yanovski; Marian Tanofsky-Kraff
Journal:  Compr Psychiatry       Date:  2013-10-18       Impact factor: 3.735

8.  Neurocognitive correlates of alexithymia in asymptomatic individuals with HIV.

Authors:  Yelena Bogdanova; Mirella Díaz-Santos; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2009-12-28       Impact factor: 3.139

9.  Alexithymia and its impact on quality of life in a group of Brazilian women with migraine without aura.

Authors:  Rebeca Veras de Andrade Vieira; Daniel Chaves Vieira; William Barbosa Gomes; Gustavo Gauer
Journal:  J Headache Pain       Date:  2013-02-25       Impact factor: 7.277

10.  Parental bonding and personality characteristics of first episode intention to suicide or deliberate self-harm without a history of mental disorders.

Authors:  Ya-Fen Hsu; Po-Fei Chen; For-Wey Lung
Journal:  BMC Public Health       Date:  2013-05-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.